Zoetis Inc. (ZTS)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
156.48-2.57 (-1.62%)
At close: 4:04PM EST
| Previous close | 159.05 |
| Open | 158.50 |
| Bid | 0.00 x 1800 |
| Ask | 0.00 x 800 |
| Day's range | 155.75 - 159.45 |
| 52-week range | 90.14 - 176.64 |
| Volume | 2,021,688 |
| Avg. volume | 1,811,701 |
| Market cap | 74.378B |
| Beta (5Y monthly) | 0.64 |
| PE ratio (TTM) | 45.75 |
| EPS (TTM) | 3.42 |
| Earnings date | 04 May 2021 - 10 May 2021 |
| Forward dividend & yield | 1.00 (0.64%) |
| Ex-dividend date | 20 Apr 2021 |
| 1y target est | 188.14 |
- Business Wire
Zoetis to Participate in the Cowen 41st Annual Health Care Conference
Zoetis will participate in the Cowen 41st Annual Health Care Conference on Monday, March 1, 2021.
- Business Wire
Zoetis to Participate in the Bank of America Securities 2021 Animal Health Summit Virtual Forum
Zoetis Inc. will participate in the Bank of America Securities 2021 Animal Health Summit Virtual Forum on Thursday, Feb. 25, 2021.
- Business Wire
Zoetis Receives European Commission Marketing Authorization for Solensia® (frunevetmab), a New Therapy for Feline Osteoarthritis Pain
Zoetis receives European Commission marketing authorization for Solensia® (frunevetmab), a new therapy for feline osteoarthritis pain.
© 2021 Verizon Media. All rights reserved.
